Cargando…

Establishment of a first-line second-line treatment model for human pulmonary adenocarcinoma

Lung cancer is one of the most prevalent types of cancer in the world. Surgery, chemotherapy and radiotherapy are used clinically as treatments for numerous cancers. Due to the appearance of drug resistance, the remission rate is limited to 40–50%. Docetaxel and pemetrexed are two drugs commonly use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lining, Wang, Yu, Guan, Qi, Liu, Yong, He, Tianyi, Wang, Jiaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228578/ https://www.ncbi.nlm.nih.gov/pubmed/28105156 http://dx.doi.org/10.3892/ol.2016.5299

Ejemplares similares

Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
por: King, Gentry, et al.
Publicado: (2022)

Establishment and characterisation of six human colorectal adenocarcinoma cell lines.
por: Kirkland, S. C., et al.
Publicado: (1986)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Positioning of second‐line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
por: Pericay, Carles, et al.
Publicado: (2016)

Characterization of human gastric adenocarcinoma cell lines established from peritoneal ascites
por: Mytar, Bożenna, et al.
Publicado: (2018)

Phenotypic and molecular characterization of novel pulmonary adenocarcinoma cell lines established from a dog
por: Kobayashi, Kosuke, et al.
Publicado: (2023)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence
por: Sun, Maxine, et al.
Publicado: (2014)

Internal endoscopic drainage as first line or second line treatment in case of postsleeve gastrectomy fistulas
por: Gonzalez, J. M., et al.
Publicado: (2018)

Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment
por: Nowaczyk, Alicja, et al.
Publicado: (2022)

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
por: He, Yayi, et al.
Publicado: (2016)

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2018)

First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study
por: Taieb, Julien, et al.
Publicado: (2020)

First continuous marine sponge cell line established
por: Hesp, Kylie, et al.
Publicado: (2023)

Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study
por: Fernández, Oscar, et al.
Publicado: (2020)

Establishing a TNM-like risk classification for metachronous second pulmonary adenocarcinoma in patients with previously resected pulmonary adenocarcinoma
por: Fu, Shen-Shen, et al.
Publicado: (2022)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
por: Khan, Samsuddin, et al.
Publicado: (2014)

Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial
por: Qu, Jinglei, et al.
Publicado: (2023)

Efficiency of low dosage apatinib in post-first-line treatment of advanced lung adenocarcinoma
por: Zeng, Da-Xiong, et al.
Publicado: (2017)

The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
por: Yang, Chih-Jen, et al.
Publicado: (2017)

First- and Second-Line Treatments for Patients with Advanced Hepatocellular Carcinoma in China: A Systematic Review
por: Zhang, Lan, et al.
Publicado: (2022)

First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
por: Monde, Ngula, et al.
Publicado: (2023)

Qualitative study of patients’ decision-making when accepting second-line treatment after failure of first-line chemotherapy
por: Pujol, Jean-Louis, et al.
Publicado: (2018)

Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
por: Prabhash, Kumar
Publicado: (2019)

Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer
por: Wei, J, et al.
Publicado: (2014)

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
por: Ghosn, Marwan, et al.
Publicado: (2016)

Pancreatic adenocarcinoma: Beyond first line, where are we?
por: Cherri, Sara, et al.
Publicado: (2021)

Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus
por: Malla, Midhun, et al.
Publicado: (2022)

Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors
por: Matsumoto, Takashi, et al.
Publicado: (2021)

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung
por: Kalinina, Tatyana, et al.
Publicado: (2010)

Establishment of Cell Lines with High‐ and Low‐metastatic Potential from PC‐14 Human Lung Adenocarcinoma
por: Shindo‐Okada, Nobuko, et al.
Publicado: (2001)

Establishment of Cell Lines with High and Low Metastatic Potential from A549 Human Lung Adenocarcinoma
por: Shindo‐Okada, Nobuko, et al.
Publicado: (2002)

Establishment and characterization of adult human gastric epithelial progenitor‐like cell lines
por: Gao, Yuan, et al.
Publicado: (2022)

NGS-Based ctDNA Profiling After the Resistance of Second-Line Osimertinib for Patient with EGFR-Mutated Pulmonary Adenocarcinoma
por: Li, Dan, et al.
Publicado: (2021)

Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma
por: Ulusakarya, Ayhan, et al.
Publicado: (2019)

Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma
por: Lu, Bin, et al.
Publicado: (2019)

Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma
por: Géczi, Lajos, et al.
Publicado: (2020)

Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment
por: Vashist, Yogesh, et al.
Publicado: (2022)

Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern Uganda
por: Orikiriza, Patrick, et al.
Publicado: (2015)

Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China
por: Wang, Jing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_42ou1u70r10da4rqj424s2ofml